Announcements Trials
Browse Landscape

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 10NETWORK 5

Study Type

Observational 5

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Breast 1

Conditions

Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Leukemia, Myeloid, Acute 1Leukemia 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 213Cisplatin 180Cyclophosphamide 168Doxorubicin 135Paclitaxel 125Vincristine 124Filgrastim 121Etoposide 103Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × NETWORK × Comparative Genomic Hybridization × Clear all
NCT00897936 2020-07-31

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Completed
418 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT01169376 2016-05-18

Biomarkers in Young Patients With Neuroblastoma

Children's Oncology Group

Completed
380 enrolled
CNS

Neuroblastoma

NCT01480518 2015-05-12

Biomarkers in Tissue Samples From Patients With Ewing Sarcoma

Children's Oncology Group

Completed
166 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00003096 2014-08-06

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Children's Oncology Group

Completed
88 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT00897091 2013-05-30

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

SWOG Cancer Research Network

Completed
750 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡